{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:41:02Z","timestamp":1793191262646,"version":"4.5.0"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1NR010162-01A1"],"award-info":[{"award-number":["RO1NR010162-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA122292-01"],"award-info":[{"award-number":["RO1CA122292-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA124481-01"],"award-info":[{"award-number":["RO1CA124481-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Learning Objectives<\/jats:title><jats:p>After completing this course, the reader will be able to: Summarize the current evidence regarding strategies for the assessment and management of delirium in advanced cancer.Outline the medications most commonly implicated for drug-induced delirium.Compare the various pharmacological agents available for use in managing cancer-related delirium.<\/jats:p><jats:p>This article is available for continuing medical education credit at CME.TheOncologist.com<\/jats:p><jats:p>Delirium remains the most common and distressing neuropsychiatric complication in patients with advanced cancer. Delirium causes significant distress to patients and their families, and continues to be underdiagnosed and undertreated. The most frequent, consistent, and, at the same time, reversible etiology is drug-induced delirium resulting from opioids and other psychoactive medications. The objective of this narrative review is to outline the causes of delirium in advanced cancer, especially drug-induced delirium, and the diagnosis and management of opioid-induced neurotoxicity. The early symptoms and signs of delirium and the use of delirium-specific assessment tools for routine delirium screening and monitoring in clinical practice are summarized. Finally, management options are reviewed, including pharmacological symptomatic management and also the provision of counseling support to both patients and their families to minimize distress.<\/jats:p><\/jats:sec>","DOI":"10.1634\/theoncologist.2009-0122","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T03:08:34Z","timestamp":1254884914000},"page":"1039-1049","source":"Crossref","is-referenced-by-count":102,"title":["The Assessment and Management of Delirium in Cancer Patients"],"prefix":"10.1093","volume":"14","author":[{"given":"Shirley H.","family":"Bush","sequence":"first","affiliation":[{"name":"a Department of Palliative Care & Rehabilitation Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA"},{"name":"b McCulloch House, Southern Health Care Network, Melbourne, Victoria, Australia"},{"name":"c Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia"},{"name":"d Division of Palliative Care, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[{"name":"a Department of Palliative Care & Rehabilitation Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,10,6]]},"reference":[{"key":"2021122207132182400_R1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0021-9681(59)90165-1","article-title":"Delirium, a syndrome of cerebral insufficiency","volume":"9","author":"Engel","year":"1959","journal-title":"J Chronic Dis"},{"key":"2021122207132182400_R2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0885-3924(92)90074-R","article-title":"Cognitive failure in patients with terminal cancer: A prospective study","volume":"7","author":"Bruera","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra052321","article-title":"Delirium in older persons","volume":"354","author":"Inouye","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122207132182400_R4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/jpm.2006.0257","article-title":"Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center","volume":"10","author":"Braiteh","year":"2007","journal-title":"J Palliat Med"},{"key":"2021122207132182400_R5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0885-3924(94)00075-V","article-title":"Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer","volume":"10","author":"Breitbart","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0889-8588(02)00021-7","article-title":"Delirium in patients with advanced cancer","volume":"16","author":"Lawlor","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"2021122207132182400_R7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.160.6.786","article-title":"Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study","volume":"160","author":"Lawlor","year":"2000","journal-title":"Arch Intern Med"},{"key":"2021122207132182400_R8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#","article-title":"The frequency and clinical course of cognitive impairment in patients with terminal cancer","volume":"79","author":"Pereira","year":"1997","journal-title":"Cancer"},{"key":"2021122207132182400_R9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/appi.psy.43.3.183","article-title":"The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses\/caregivers, and their nurses","volume":"43","author":"Breitbart","year":"2002","journal-title":"Psychosomatics"},{"key":"2021122207132182400_R10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.psy.45.2.107","article-title":"Family-perceived distress from delirium-related symptoms of terminally ill cancer patients","volume":"45","author":"Morita","year":"2004","journal-title":"Psychosomatics"},{"key":"2021122207132182400_R11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.24215","article-title":"Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers","volume":"115","author":"Bruera","year":"2009","journal-title":"Cancer"},{"key":"2021122207132182400_R12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ageing\/afl005","article-title":"Occurrence and outcome of delirium in medical in-patients: A systematic literature review","volume":"35","author":"Siddiqi","year":"2006","journal-title":"Age Ageing"},{"key":"2021122207132182400_R13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/jpm.2007.0241","article-title":"Factors associated with falls in patients with cancer hospitalized for palliative care","volume":"11","author":"Pautex","year":"2008","journal-title":"J Palliat Med"},{"key":"2021122207132182400_R14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X","article-title":"Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care","volume":"89","author":"Caraceni","year":"2000","journal-title":"Cancer"},{"key":"2021122207132182400_R15","first-page":"141","volume-title":"Delirium due to a general medical condition. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Text Revision","year":"2000","edition":"Fourth Edition."},{"key":"2021122207132182400_R16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1191\/0269216304pm879oa","article-title":"Delirium in advanced cancer patients","volume":"18","author":"Centeno","year":"2004","journal-title":"Palliat Med"},{"key":"2021122207132182400_R17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1176\/ajp.140.8.1048","article-title":"Delirium in terminally ill cancer patients","volume":"140","author":"Massie","year":"1983","journal-title":"Am J Psychiatry"},{"key":"2021122207132182400_R18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1192\/bjp.161.6.843","article-title":"An empirical study of delirium subtypes","volume":"161","author":"Liptzin","year":"1992","journal-title":"Br J Psychiatry"},{"key":"2021122207132182400_R19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/jnp.2008.20.2.185","article-title":"A new data-based motor subtype schema for delirium","volume":"20","author":"Meagher","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2021122207132182400_R20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4088\/JCP.v68n0102","article-title":"Antipsychotics in the treatment of delirium: A systematic review","volume":"68","author":"Seitz","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"2021122207132182400_R21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.psy.43.3.175","article-title":"An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients","volume":"43","author":"Breitbart","year":"2002","journal-title":"Psychosomatics"},{"key":"2021122207132182400_R22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S1478951508000266","article-title":"An update on the use of antipsychotics in the treatment of delirium","volume":"6","author":"Alici-Evcimen","year":"2008","journal-title":"Palliat Support Care"},{"key":"2021122207132182400_R23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1191\/0269216306pm1097oa","article-title":"Hypoactive delirium: Assessing the extent of the problem for inpatient specialist palliative care","volume":"20","author":"Spiller","year":"2006","journal-title":"Palliat Med"},{"key":"2021122207132182400_R24","first-page":"106","article-title":"Phenomenology of delirium and its subtypes in advanced cancer patients: A prospective study [abstract]","volume":"14","author":"Lawlor","year":"1998","journal-title":"J Palliat Care"},{"key":"2021122207132182400_R25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0885-3924(01)00360-8","article-title":"Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients","volume":"22","author":"Morita","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0885-3924(92)90060-U","article-title":"The assessment of pain intensity in patients with cognitive failure: A preliminary report","volume":"7","author":"Bruera","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R27","first-page":"132","article-title":"Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine","volume":"5","author":"Trzepacz","year":"2000","journal-title":"Semin Clin Neuropsychiatry"},{"key":"2021122207132182400_R28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CCO.0b013e328302167d","article-title":"Delirium in cancer patients: A focus on treatment-induced psychopathology","volume":"20","author":"Agar","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"2021122207132182400_R29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/J354v21n01_05","article-title":"Adverse effects of opioids on the central nervous systems of palliative care patients","volume":"21","author":"Vella-Brincat","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2021122207132182400_R30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychores.2006.11.013","article-title":"Cytokines and acute phase response in delirium","volume":"62","author":"Rooij","year":"2007","journal-title":"J Psychosom Res"},{"key":"2021122207132182400_R31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/afp014","article-title":"Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients","volume":"38","author":"Adamis","year":"2009","journal-title":"Age Ageing"},{"key":"2021122207132182400_R32","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1532-5415.2008.01851.x","article-title":"Time-course of cytokines during delirium in elderly patients with hip fractures","volume":"56","author":"Munster","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"2021122207132182400_R33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.mehy.2004.08.007","article-title":"Psychotogenic drugs and delirium pathogenesis: The central role of the thalamus","volume":"64","author":"Gaudreau","year":"2005","journal-title":"Med Hypotheses"},{"key":"2021122207132182400_R34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0163-8343(03)00070-7","article-title":"Risk factors for development of delirium among oncology patients","volume":"25","author":"Ljubisavljevic","year":"2003","journal-title":"Gen Hosp Psychiatry"},{"key":"2021122207132182400_R35","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1200\/JCO.2005.05.140","article-title":"Psychoactive medications and risk of delirium in hospitalized cancer patients","volume":"23","author":"Gaudreau","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122207132182400_R36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients","volume":"161","author":"Han","year":"2001","journal-title":"Arch Intern Med"},{"key":"2021122207132182400_R37","first-page":"717","volume-title":"Proceedings of the 8th World Congress on Pain: Progress in Pain Research and Management","author":"Bruera","year":"1997"},{"key":"2021122207132182400_R38","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","article-title":"Opioid rotation for cancer pain: Rationale and clinical aspects","volume":"86","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"key":"2021122207132182400_R39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000138294","article-title":"Reversible, narcotic-associated mental status impairment in patients with metastatic cancer","volume":"35","author":"Leipzig","year":"1987","journal-title":"Pharmacology"},{"key":"2021122207132182400_R40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1191\/026921601674921626","article-title":"Visual hallucinations: A prevalence study among hospice inpatients","volume":"15","author":"Fountain","year":"2001","journal-title":"Palliat Med"},{"key":"2021122207132182400_R41","first-page":"380","volume-title":"Opioid analgesics. Textbook of Palliative Medicine","author":"Sj\u00f8gren","year":"2006"},{"key":"2021122207132182400_R42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat","volume":"48","author":"Gong","year":"1992","journal-title":"Pain"},{"key":"2021122207132182400_R43","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide","volume":"90","author":"Penson","year":"2001","journal-title":"J Pharm Sci"},{"key":"2021122207132182400_R44","first-page":"163","volume-title":"Topics in Palliative Care","author":"Sj\u00f8gren","year":"1997"},{"key":"2021122207132182400_R45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","article-title":"Hyperalgesia: An emerging iatrogenic syndrome","volume":"26","author":"Mercadante","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpsychores.2008.05.020","article-title":"Delirium phenomenology: What can we learn from the symptoms of delirium?","volume":"65","author":"Gupta","year":"2008","journal-title":"J Psychosom Res"},{"key":"2021122207132182400_R47","first-page":"746","volume-title":"Psychiatric symptoms in palliative medicine. Oxford Textbook of Palliative Medicine","author":"Breitbart","year":"2004","edition":"Third Edition."},{"key":"2021122207132182400_R48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/026921639701100206","article-title":"Dysgraphia and terminal delirium","volume":"11","author":"Macleod","year":"1997","journal-title":"Palliat Med"},{"key":"2021122207132182400_R49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0140-6736(93)90117-Y","article-title":"Cognitive failure in cancer patients in clinical trials [letter]","volume":"341","author":"Bruera","year":"1993","journal-title":"Lancet"},{"key":"2021122207132182400_R50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2021122207132182400_R51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0885-3924(95)00005-J","article-title":"Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation","volume":"10","author":"Bruera","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/ajp.153.2.231","article-title":"A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients","volume":"153","author":"Breitbart","year":"1996","journal-title":"Am J Psychiatry"},{"key":"2021122207132182400_R53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1191\/0269216304pm920oa","article-title":"Methods for assessment of cognitive failure and delirium in palliative care patients: Implications for practice and research","volume":"18","author":"Hjermstad","year":"2004","journal-title":"Palliat Med"},{"key":"2021122207132182400_R54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0885-3924(94)00066-T","article-title":"A critique of instruments and methods to detect, diagnose, and rate delirium","volume":"10","author":"Smith","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpsychores.2008.05.024","article-title":"Delirium detection in clinical practice and research: Critique of current tools and suggestions for future development","volume":"65","author":"Kean","year":"2008","journal-title":"J Psychosom Res"},{"key":"2021122207132182400_R56","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-113-12-941","article-title":"Clarifying confusion: The confusion assessment method. A new method for detection of delirium","volume":"113","author":"Inouye","year":"1990","journal-title":"Ann Intern Med"},{"key":"2021122207132182400_R57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0885-3924(96)00316-8","article-title":"The Memorial Delirium Assessment Scale","volume":"13","author":"Breitbart","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R58","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/1097-0142(20000615)88:12<2859::AID-CNCR29>3.0.CO;2-T","article-title":"Clinical utility, factor analysis, and further validation of the Memorial Delirium Assessment Scale in patients with advanced cancer: Assessing delirium in advanced cancer","volume":"88","author":"Lawlor","year":"2000","journal-title":"Cancer"},{"key":"2021122207132182400_R59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpainsymman.2004.07.009","article-title":"Fast, systematic, and continuous delirium assessment in hospitalized patients: The nursing delirium screening scale","volume":"29","author":"Gaudreau","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0885-3924(00)00143-3","article-title":"Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring","volume":"19","author":"Gagnon","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269216308099210","article-title":"Validation of the confusion assessment method in the palliative care setting","volume":"23","author":"Ryan","year":"2009","journal-title":"Palliat Med"},{"key":"2021122207132182400_R62","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00520-007-0247-6","article-title":"Evaluation of the Memorial Delirium Assessment Scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals","volume":"15","author":"Fadul","year":"2007","journal-title":"Support Care Cancer"},{"key":"2021122207132182400_R63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients","volume":"7","author":"Bruera","year":"1991","journal-title":"J Palliat Care"},{"key":"2021122207132182400_R64","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","article-title":"Opioid rotation for toxicity reduction in terminal cancer patients","volume":"10","author":"Stoutz","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2002.20.1.348","article-title":"Opioid rotation in the management of refractory cancer pain","volume":"20","author":"Indelicato","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122207132182400_R66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","article-title":"Opioid switching: A systematic and critical review","volume":"32","author":"Mercadante","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"2021122207132182400_R67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-3959(92)90146-3","article-title":"Clonazepam treatment of myoclonic contractions associated with high-dose opioids: Case report","volume":"49","author":"Eisele","year":"1992","journal-title":"Pain"},{"key":"2021122207132182400_R68","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpainsymman.2003.07.002","article-title":"Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: A case report","volume":"27","author":"Slatkin","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R69","doi-asserted-by":"publisher","first-page":"CD005317","DOI":"10.1002\/14651858.CD005317.pub2","article-title":"Cholinesterase inhibitors for delirium","volume-title":"Cochrane Database Syst Rev","author":"Overshott","year":"2008"},{"key":"2021122207132182400_R70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2165\/00023210-200822080-00002","article-title":"Delirium and its treatment","volume":"22","author":"Attard","year":"2008","journal-title":"CNS Drugs"},{"key":"2021122207132182400_R71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychores.2008.05.025","article-title":"Drug treatment of delirium: Past, present and future","volume":"65","author":"Bourne","year":"2008","journal-title":"J Psychosom Res"},{"key":"2021122207132182400_R72","first-page":"103","volume-title":"Hospice and Palliative Care Formulary USA","author":"Twycross","year":"2006"},{"key":"2021122207132182400_R73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1478951505050352","article-title":"Atypical antipsychotics in the management of delirium: A review of the empirical literature","volume":"3","author":"Boettger","year":"2005","journal-title":"Palliat Support Care"},{"key":"2021122207132182400_R74","first-page":"100","article-title":"Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: A prospective clinical study","volume":"30","author":"Gagnon","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"2021122207132182400_R75","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1001\/jama.2008.885","article-title":"Agitation and delirium at the end of life: \u201cWe couldn't manage him.\u201d","volume":"300","author":"Breitbart","year":"2008","journal-title":"JAMA"},{"key":"2021122207132182400_R76","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1213\/00000539-200202000-00019","article-title":"Melatonin for treatment and prevention of postoperative delirium","volume":"94","author":"Hanania","year":"2002","journal-title":"Anesth Analg"},{"key":"2021122207132182400_R77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(97)01457-X","article-title":"Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam","volume":"342","author":"Nakamura","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"2021122207132182400_R78","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/jnp.17.2.232","article-title":"Adjunctive valproic acid for delirium and\/or agitation on a consultation-liaison service: A report of six cases","volume":"17","author":"Bourgeois","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2021122207132182400_R79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2009.56","article-title":"Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial","volume":"301","author":"Riker","year":"2009","journal-title":"JAMA"},{"key":"2021122207132182400_R80","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/mtc.2001.108726","article-title":"Ondansetron hydrochloride for the treatment of delirium after coronary artery surgery","volume":"121","author":"Bayindir","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021122207132182400_R81","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1345\/aph.1H241","article-title":"Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients","volume":"40","author":"Lacasse","year":"2006","journal-title":"Ann Pharmacother"},{"key":"2021122207132182400_R82","doi-asserted-by":"publisher","first-page":"CD004770","DOI":"10.1002\/14651858.CD004770","article-title":"Drug therapy for delirium in terminally ill patients","volume-title":"Cochrane Database Syst Rev","author":"Jackson","year":"2004"},{"key":"2021122207132182400_R83","doi-asserted-by":"publisher","first-page":"CD005594","DOI":"10.1002\/14651858.CD005594.pub2","article-title":"Antipsychotics for delirium","volume-title":"Cochrane Database Syst Rev","author":"Lonergan","year":"2007"},{"key":"2021122207132182400_R84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1191\/0269216304pm881oa","article-title":"Haloperidol in palliative care","volume":"18","author":"Vella-Brincat","year":"2004","journal-title":"Palliat Med"},{"key":"2021122207132182400_R85","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s007020100006","article-title":"Clinical characteristics of neuroleptic-induced parkinsonism","volume":"108","author":"Hassin-Baer","year":"2001","journal-title":"J Neural Transm"},{"issue":"suppl 5","key":"2021122207132182400_R86","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium","volume":"156","author":"American Psychiatric Association (APA)","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2021122207132182400_R87","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-135-1-200107030-00011","article-title":"Diagnosis and management of delirium near the end of life","volume":"135","author":"Casarett","year":"2001","journal-title":"Ann Intern Med"},{"key":"2021122207132182400_R88","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01788847","article-title":"Usage of haloperidol for delirium in cancer patients","volume":"4","author":"Akechi","year":"1996","journal-title":"Support Care Cancer"},{"key":"2021122207132182400_R89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF01788841","article-title":"A retrospective study of the psychiatric management and outcome of delirium in the cancer patient","volume":"4","author":"Olofsson","year":"1996","journal-title":"Support Care Cancer"},{"key":"2021122207132182400_R90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/jnp.6.1.66","article-title":"Efficacy of neuroleptics for hypoactive delirium","volume":"6","author":"Platt","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2021122207132182400_R91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0163-8343(03)00024-0","article-title":"Treatment for delirium with risperidone: Results of a prospective open trial with 10 patients","volume":"25","author":"Horikawa","year":"2003","journal-title":"Gen Hosp Psychiatry"},{"key":"2021122207132182400_R92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1479-8301.2007.00182.x","article-title":"Successful treatment with quetiapine for delirium in terminally ill cancer patients","volume":"7","author":"Shinno","year":"2007","journal-title":"Psychogeriatrics"},{"key":"2021122207132182400_R93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1176\/appi.psy.47.5.385","article-title":"Aripiprazole in the treatment of delirium","volume":"47","author":"Straker","year":"2006","journal-title":"Psychosomatics"},{"key":"2021122207132182400_R94","doi-asserted-by":"publisher","first-page":"CD005237","DOI":"10.1002\/14651858.CD005237.pub2","article-title":"Risperidone versus olanzapine for schizophrenia","volume-title":"Cochrane Database Syst Rev","author":"Jayaram","year":"2006"},{"key":"2021122207132182400_R95","first-page":"457","article-title":"Subcutaneous olanzapine for hyperactive or mixed delirium in a comprehensive cancer center [abstract 191]","volume":"22","author":"Delgado-Guay","year":"2008","journal-title":"Palliat Med"},{"key":"2021122207132182400_R96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"2021122207132182400_R97","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"2021122207132182400_R98","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs. atypical antipsychotic medications","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"2021122207132182400_R99","volume-title":"Deaths With Antipsychotics in Elderly Patients With Behavioral Disturbances","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"2021122207132182400_R100","volume-title":"Conventional Antipsychotics \u2013 Healthcare Professional Sheet Text Version","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"2021122207132182400_R101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"2021122207132182400_R102","volume-title":"Haloperidol (Marketed as Haldol, Haldol Decanoate and Haldol Lactate)","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"2021122207132182400_R103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.psy.50.1.8","article-title":"Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: Case reports and a review of the literature","volume":"50","author":"Seitz","year":"2009","journal-title":"Psychosomatics"},{"key":"2021122207132182400_R104","first-page":"529","article-title":"Delirium in patients with cancer: Nursing assessment and intervention","volume":"17","author":"Zimberg","year":"1990","journal-title":"Oncol Nurs Forum"},{"key":"2021122207132182400_R105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/082585970201800402","article-title":"Delirium in advanced cancer: A psychoeducational intervention for family caregivers","volume":"18","author":"Gagnon","year":"2002","journal-title":"J Palliat Care"},{"key":"2021122207132182400_R106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00335899","article-title":"Essentials of psychotherapeutic intervention for cancer patients","volume":"3","author":"Spiegel","year":"1995","journal-title":"Support Care Cancer"},{"key":"2021122207132182400_R107","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00520-008-0459-4","article-title":"Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center","volume":"17","author":"Elsayem","year":"2009","journal-title":"Support Care Cancer"},{"key":"2021122207132182400_R108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jpm.2006.0139","article-title":"Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards","volume":"10","author":"Graeff","year":"2007","journal-title":"J Palliat Med"},{"key":"2021122207132182400_R109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/026921698671831786","article-title":"Sedation for intractable distress in the dying\u2014a survey of experts","volume":"12","author":"Chater","year":"1998","journal-title":"Palliat Med"},{"key":"2021122207132182400_R110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5694\/j.1326-5377.1991.tb93848.x","article-title":"Terminal restlessness\u2014its management and the role of midazolam","volume":"155","author":"Burke","year":"1991","journal-title":"Med J Aust"},{"key":"2021122207132182400_R111","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0885-3924(99)00006-8","article-title":"The use of phenobarbitone in the management of agitation and seizures at the end of life","volume":"17","author":"Stirling","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R112","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jpainsymman.2005.05.017","article-title":"When nothing helps: Propofol as sedative and antiemetic in palliative cancer care","volume":"30","author":"Lundstr\u00f6m","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"2021122207132182400_R113","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","article-title":"Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations\u2013a study by the Steering Committee of the European Association for Palliative Care","volume":"23","author":"Maltoni","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122207132182400_R114","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/0269216308094520","article-title":"Reversibility of delirium in terminally ill patients and predictors of mortality","volume":"22","author":"Leonard","year":"2008","journal-title":"Palliat Med"},{"key":"2021122207132182400_R115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ageing\/afn253","article-title":"Persistent delirium in older hospital patients: A systematic review of frequency and prognosis","volume":"38","author":"Cole","year":"2009","journal-title":"Age Ageing"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2009-0122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2009-0122","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/14\/10\/1039\/41842006\/oncolo_14_10_1039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/14\/10\/1039\/41842006\/oncolo_14_10_1039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T02:12:44Z","timestamp":1685153564000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/14\/10\/1039\/6398044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":115,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,6]]},"published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2009-0122","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,10,1]]},"published":{"date-parts":[[2009,10,1]]}}}